Daniel S. Robins

President & CEO at Capstone Development Services

Leading with intention and having a background of robust leadership, Dan Robins, Ph.D., has nearly 30 years of pharmaceutical industry experience. With a product portfolio of growth at Mylan, Bioniche Pharma, and Abraxis BioScience, he’s also held leadership positions at Barr Laboratories, Inc. and scientific roles at Schering-Plough Research Institute, Mallinckrodt Veterinary, and Pentech Pharmaceuticals. With an emphasis research and development, Dan is making a mark on healthcare brands -one launch at a time.

Links

Timeline

  • President & CEO

    Current role